AppYea News

News

Ticker

APYP

ISIN

US03834R2058

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

AppYea Eulerpool News

AppYea Stock News

AppYea is being monitored by journalists and investors worldwide. We gather the latest AppYea news here.

October 15·
Yahoo
Appyea, Inc. (OTCQB: APYP) Unveils Techlott--a Blockchain Engine for End-to-End Transparency in Gaming; Announces Strategic Entry into Prediction Markets and Releases Full September 16, 2025 Conference Transcript
August 27·
Yahoo
AppYea Sets September 16 Live Investor Briefing With Newly Appointed CEO Yakir Abadi; Management to Present First-Deployment Roadmap, and Expanded Gaming Modules Following Techlott Integration
August 14·
Yahoo
Yakir Abadi, Recognized Fintech and Blockchain Leader, Joins AppYea (OTCQB: APYP) as CEO
September 30·
Yahoo
AppYea Launches Smart Biofeedback-Based Wristband to Address Snoring

AppYea Stock Press Releases

AppYea regularly publishes news on the company's website that are relevant for investors.

AppYea News 2026

This page contains all current news, analysis and press releases for AppYea stock (APYP, ISIN: US03834R2058). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at AppYea.

AppYea Stock

AppYea AppYea Inc develops wearable monitoring solutions for sleep apnea and snoring treatment, focusing on the DreamIT wristband for snoring biofeedback and the DreamIT PRO wristband for sleep apnea treatment. The SleepX App monitors physiological parameters during sleep using algorithms developed by SleepX, while SleepX PRO is a medical application that identifies sleep apnea episodes without direct user contact. These products target patients seeking non-invasive sleep disorder management through wearable technology. The company's revenue streams come from direct sales of DreamIT, DreamIT PRO, and SleepX PRO to end-users, with the SleepX PRO app specifically positioned as a medical application for sleep apnea monitoring. The DreamIT and DreamIT PRO devices are sold alongside their respective apps, creating a bundled offering for consumers managing sleep-related health issues. The SleepX PRO app's medical certification enables it to be marketed as a healthcare solution rather than a general wellness tool. AppYea Inc's target market includes individuals diagnosed with sleep apnea or chronic snoring, who prefer wearable technology over traditional CPAP machines. The company positions its products as alternatives to conventional treatments, emphasizing convenience and non-invasive monitoring through the SleepX algorithms that process sensor data during sleep. Sales are driven by the medical application status of SleepX PRO, which differentiates it from consumer wellness apps.